8th May 2009 07:00
MEDERMICA FILES TECHNOLOGY PATENT
IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is pleased to announce that its portfolio company, Medermica Limited ("Medermica"), has filed a patent application relating to a novel technology for the measurement of pH.
Medermica's innovative pH measuring device uses ultra small volumes of liquid and is cheap, accurate, rapid and disposable. This valuable technology is relevant to a wide range of commercial, industrial and medical applications, which currently use traditional pH measuring techniques, including pharmaceutical manufacturing, food processing and research.
Medermica is expected to commence discussions with potential commercial partners in the next six months.
Peter Knox, Chairman of Medermica and a non executive director of IPSO said: "Our technology is a considerable leap forward in an area that has not changed for decades and there is a considerable potential market for such a device."
Medermica is a technology development company, focused on diagnostic and sensor technologies for laboratory or healthcare applications. It was created by IPSO in May 2006 to progress certain sensor technologies which have been developed by Dr Danny O'Hare, Reader in Sensor Research in the Department of Bioengineering at Imperial College. Imperial Innovations plc is a shareholder in Medermica.
Further information, please contact:
|
IPSO Ventures plc: Simon Hunt, Chairman Nick Rodgers, Chief Executive |
Tel: 020 7921 2990 |
|
Website details: |
www.ipsoventures.com |
|
Ambrian Partners Limited Samantha Harrison |
Tel: 020 7634 4700 |
|
Rawlings Financial PR Limited Catriona Valentine |
Tel: 01653 618 016 |
NOTES TO EDITORS
IPSO:
IPSO creates commercial value from technology and its business model is entirely demand driven. It works closely with its industrial collaborators to identify the demand for new, innovative technologies and then, through its strong relationships with research institutions, sources technologies which could meet those needs. Much of this technology requires considerable further work by IPSO before it can be sold to industry as a developed product. IPSO creates businesses and provides expertise, strategic direction, human and seed capital, as well as corporate finance advice.
For industrial collaborators, IPSO provides a mechanism to identify and develop technologies which could be of significant value to their businesses and removes the risk to them of acquiring raw, unproven and undeveloped technology.
For research institutions, IPSO provides greater certainty that their technology will find commercial success.
Related Shares:
PPG.L